ENVESTNET ASSET MANAGEMENT INC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$616,808
+20.9%
13,118
+7.9%
0.00%
Q1 2023$509,982
+21.5%
12,154
+10.5%
0.00%
Q4 2022$419,578
+1.8%
11,001
+4.6%
0.00%
Q3 2022$412,000
+24.1%
10,513
+2.4%
0.00%
Q2 2022$332,000
-12.9%
10,271
-10.8%
0.00%
Q1 2022$381,000
-61.0%
11,512
-49.8%
0.00%
Q4 2021$976,000
+89.9%
22,948
+98.0%
0.00%
Q3 2021$514,000
-30.4%
11,590
-10.9%
0.00%
Q2 2021$739,000
+14.6%
13,009
+51.0%
0.00%
Q1 2021$645,000
+112.9%
8,614
+146.3%
0.00%
Q4 2020$303,000
-32.7%
3,498
-43.8%
0.00%
Q4 2019$450,000
-74.2%
6,228
-49.8%
0.00%
-100.0%
Q3 2019$1,741,000
-17.0%
12,413
+8.3%
0.00%
-33.3%
Q2 2019$2,098,000
+41.5%
11,459
+22.9%
0.00%
+50.0%
Q1 2019$1,483,000
+106.8%
9,324
+24.5%
0.00%
+100.0%
Q4 2018$717,000
-26.1%
7,489
+20.8%
0.00%
-50.0%
Q2 2018$970,000
+142.5%
6,197
+149.6%
0.00%
+100.0%
Q1 2018$400,000
-7.4%
2,483
-5.4%
0.00%0.0%
Q4 2017$432,000
+137.4%
2,624
-9.7%
0.00%
Q3 2017$182,000
+33.8%
2,906
+70.7%
0.00%
Q2 2017$136,000
+11.5%
1,702
-0.4%
0.00%
Q1 2017$122,000
+35.6%
1,708
-3.4%
0.00%
Q4 2016$90,0001,7690.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders